Institutional investors purchased a net $7.5 million shares of CYTR during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 37.68% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QUANTBOT TECHNOLOGIES LLC Bought 606.00 shares of CytRx Corp
TRADEWORX, INC. Sold 16.6 Thousand shares of CytRx Corp